131
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Polycaprolactone and polycaprolactone triol blends to obtain a stable liquid nanotechnological formulation: synthesis, characterization and in vitroin vivo taste masking evaluation

ORCID Icon, , , , ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1556-1567 | Received 29 Mar 2021, Accepted 22 Nov 2021, Published online: 09 Dec 2021

6. References

  • Kausar A, Zulfiqar S, Sarwar MI. Nanoblends of PMMA/aramid: a study on morphological and physical properties. Solid State Sci. 2013;24:36–43.
  • Qiang Y, Manohar N, Stebe KJ, et al. Polymer blend-filled nanoparticle films via monomer-driven infiltration of polymer and photopolymerization. Mol Syst Des Eng. 2018;3(1):96–102.
  • Sionkowska A. Current research on the blends of natural and synthetic polymers as new biomaterials. Prog Polym Sci. 2011;36(9):1254–1276.
  • Imre B, Pukánszky B. Compatibilization in bio-based and biodegradable polymer blends. Eur Polym J. 2013;49(6):1215–1233.
  • Dashevsky A, Kolter K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm. 2004;279(1–2):19–26.
  • Strübing S, Metz H, Mäder K. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery. Eur J Pharm Biopharm. 2007;66(1):113–119.
  • Pathak SM, Musmade P, Dengle S, et al. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin—preparation and in vitro and in vivo evaluation. Eur J Pharm Sci. 2010;41(3–4):440–451.
  • Hsu A, Granneman GR, Cao G, et al. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther. 1998;63(4):453–464.
  • Li X, Chan WK. Transport, metabolism and elimination mechanisms of anti-HIV agents. Adv Drug Deliv Rev. 1999;39(1–3):81–103.
  • Schiffman SS, Zervakis J, Heffron S, et al. Effect of protease inhibitors on the sense of taste. Nutrition. 1999;15(10):767–772.
  • Lin D, Seabrook JA, Matsui DM, et al. Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada. Pharmacoepidemiol Drug Saf. 2011;20(12):1246–1252.
  • Sharma P, Garg S. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv Drug Deliv Rev. 2010;62(4–5):491–502.
  • Souto EB, Dias-Ferreira J, Shegokar R, et al. Ethical issues in research and development of nanoparticles. Drug Delivery Aspects. Elsevier. 2020;4(7):157–168.
  • Fan Y, Chen H, Huang Z, et al. Taste-masking and colloidal-stable cubosomes loaded with Cefpodoxime proxetil for pediatric oral delivery. Int J Pharm. 2020;575:118875.
  • Omar SM, Ibrahim F, Ismail A. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste. Saudi Pharm J. 2020;28(3):349–361.
  • Giaretta M, Bianchin MD, Kanis LA, et al. Development of innovative polymer-based matricial nanostructures for ritonavir oral administration. J Nanomater. 2019;2019:1–10.
  • Felton LA. Use of polymers for taste-masking pediatric drug products. Drug Dev Ind Pharm. 2018;44(7):1049–1055.
  • Taki M, Tagami T, Ozeki T. Preparation of polymer-blended quinine nanocomposite particles by spray drying and assessment of their instrumental bitterness-masking effect using a taste sensor. Drug Dev Ind Pharm. 2017;43(5):715–722.
  • Nair LS, Laurencin CT. Biodegradable polymers as biomaterials". Prog Polym Sci. 2007;32(8–9):762–798.
  • Woodruff MA, Hutmacher DW. The return of a forgotten polymer—polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–1256.
  • Mondal D, Griffith M, Venkatraman SS. Polycaprolactone based biomaterials for tissue engineering and drug delivery: current scenario and challenges. Int J Polym Mater. 2016;65(5):255–265.
  • Schmidt V, Soldi V. Influence of polycaprolactone-triol addition on thermal stability of soy protein isolate based films. Polym Degrad Stab. 2006;91(12):3124–3130.
  • Suedee R, Jantarat C, Lindner W, et al. Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs. J Control Release. 2010;142(1):122–131.
  • Kanis LA, Soldi V. Poly (ethylene-co-methyl acrylate)/poly (caprolactone) triol blends for drug delivery systems: characterization and drug release. Quím Nova. 2012;35(2):297–300.
  • Minata MK, Motta AC, Barbo MLP, et al. Biocompatibility study of Poly(L-acid-latic)/Polycaprolactone triol blend. Polímeros. 2013;23(2):242–247.
  • Jäger E, Venturini CG, Poletto FS, et al. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol. 2009;5(1):130–140.
  • Krieser K, Emanuelli J, Daudt RM, et al. Taste-masked nanoparticles containing saquinavir for pediatric oral administration. Mater Sci Eng C Mater Biol Appl. 2020;117:111315.
  • Yu M, Yuan W, Li D, et al. Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release. 2019;315:23–30.
  • Emanuelli J, Krieser K, Guerreiro IK, et al. Saquinavir solubility study. Mendeley Data. 2020;1.
  • Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2015;111(1):A3.B.1–A3.B.3.
  • Facure MHM, Schneider R, Dos Santos DM, et al. Impedimetric electronic tongue based on molybdenum disulfide and graphene oxide for monitoring antibiotics in liquid media. Talanta. 2020;217:121039.
  • Correa DS, Medeiros ES, Oliveira JE, et al. Nanostructured conjugated polymers in chemical sensors: synthesis, properties and applications. J Nanosci Nanotechnol. 2014;14(9):6509–6527.
  • Hoffmeister CRD, Fandaruff C, Da Costa MA, et al. Efavirenz dissolution enhancement III: colloid milling, pharmacokinetics and electronic tongue evaluation. Eur J Pharm Sci. 2017;99:310–317.
  • Hassan PA, Rana S, Verma G. Making sense of Brownian motion: colloid characterization by dynamic light scattering. Langmuir. 2015;31(1):3–12.
  • Cattani VB, Fiel LA, Jäger A, et al. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur J Pharm Sci. 2010;39(1–3):116–124.
  • Külkamp IC, Paese K, Guterres SS, et al. Stabilization of lipoic acid by encapsulation in polymeric nanocapsules designed for cutaneous. Quím Nova. 2009;32(8):2078–2084.
  • Olejnik A, Schroeder G, Nowak I. The tetrapeptide N-acetyl-Pro-Pro-Tyr-Leu in skin care formulations-physicochemical and release studies. Int J Pharm. 2015;492(1–2):161–168.
  • Mengual O, Meunier G, Cayré I, et al. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta. 1999;50(2):445–456.
  • Manadas R, Pina ME, Veiga F. Dissolution studies in vitro as a prognostic tool for oral absoption of modified release pharmaceutical dosage forms. Braz. J Pharm Sci. 2002;38(4):375–399.
  • Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev. 2012;64:163–174.
  • Schaffazick SR, Guterres SS, Freitas LL, et al. Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration. Quím Nova. 2003;26(5):726–737.
  • Mennella JA, Mathew PS, Lowenthal ED. Use of adult sensory panel to study individual differences in the palatability of a pediatric HIV treatment drug. Clin Ther. 2017;39(10):2038–2048.
  • Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.
  • Rogošić M, Mencer HJ, Gomzi Z. Polydispersity index and molecular weight distributions of polymers. Eur Polym J. 1996;32(11):1337–1344.
  • Diyanat M, Saeidian H, Baziar S, et al. Preparation and characterization of polycaprolactone nanocapsules containing pretilachlor as a herbicide nanocarrier. Environ Sci Pollut Res Int. 2019;26(21):21579–21588.
  • Fraj A, Jaâfar F, Marti M, et al. A comparative study of oregano (Origanum vulgare L.) essential oil-based polycaprolactone nanocapsules/microspheres: preparation, physicochemical characterization, and storage stability. Ind Crops Prod. 2019;140:111669.
  • Khoobdel M, Ahsaei SM, Farzaneh M. Insecticidal activity of polycaprolactone nanocapsules loaded with Rosmarinus officinalis essential oil in Tribolium castaneum (Herbst). Entomol Res. 2017;47(3):175–184.
  • Paese K, Jäger A, Poletto FS, et al. Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol. 2009;5(3):240–246.
  • Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1–2):113–142.
  • Lemarchand C, Couvreur P, Vauthier C, et al. Study of emulsion stabilization by graft copolymers using the optical analyzer Turbiscan. Int J Pharm. 2003;254(1):77–82.
  • Ephrem E, Greige-Gerges H, Fessi H, et al. Optimisation of rosemary oil encapsulation in polycaprolactone and scale-up of the process. J Microencapsul. 2014;31(8):746–753.
  • Washington C. Drug release from microdisperse systems: a critical review. Int J Pharm. 1990;58(1):1–12.
  • Hoet PHM, Brüske-Hohlfeld I, Salata OV. Nanoparticles – known and unknown health risks. J Nanobiotechnol. 2004;2(1):12.
  • Medina C, Santos-Martinez MJ, Radomski A, et al. Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol. 2007;150(5):552–558.
  • Chueh PJ, Liang RY, Lee YH, et al. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J Hazard Mater. 2014;264:303–312.
  • Mao Z, Wang B, Ma L, et al. The influence of polycaprolactone coating on the internalization and cytotoxicity of gold nanoparticles. Nanomedicine. 2007;3(3):215–223.
  • Kourrouski MFC, Lima RAG. Treatment adherence: the experience of adolescents with HIV/AIDS. Rev Lat Am Enfermagem. 2009;17(6):947–952.
  • Melvin AJ, Mohan KMA, Arcuino LAM, et al. Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Pediatr Infect Dis J. 1997;16(10):968–974.
  • Guedes MDV, Marques MS, Guedes PC, et al. The use of electronic tongue and sensory panel on taste evaluation of pediatric medicines: a systematic review. Pharm Dev Technol. 2021;26(2):119–137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.